All posts by imreal

MD Logic Health Announces New Partnership with Cynthia Thurlow


“I chose to work with MD Logic because of my professional insights and personal experience regarding their ethical, clean, and complete label transparency” stated Cynthia Thurlow.

MD Logic Health (“MD Logic”), a leading provider of professional-grade nutraceuticals and physician-recommended dietary supplements made in the USA, announced a major partnership with Cynthia Thurlow.

This collaboration was possible because of our mutual philosophy to create supplements made from the purest, ethically, and sustainably sourced raw materials to create potent and effective nutraceuticals.

“I chose to work with MD Logic because of my professional insights and personal experience regarding their ethical, clean, and complete label transparency. MD Logic’s strict standards and double laboratory analysis of each ingredient are unparalleled. Manufacturing is done in a USA GMP-certified facility that is precise about the Purity, Potency, Identity, and Strength of every ingredient,” stated Cynthia Thurlow.

The first product under this collaboration is Creatine Monohydrate by Cynthia Thurlow, powered by MD Logic Health. Creatine is a naturally occurring organic compound composed of three amino acids: arginine, glycine, and methionine.

We selected Creatine Monohydrate because of the substantial evidence and clinical data supporting muscle and brain function. In addition, both are shown to be leading predictors of health span and longevity.

Creatine has been shown to support muscle strength, endurance, and growth in men, women, and people over fifty. Emerging and ongoing research has demonstrated the power of Creatine Monohydrate. Research has also shown that Creatine Monohydrate supports the brain’s energy requirements and supports focus, memory, and intense brain activity.

MD Logic Cofounder Scott Emmens added, “Our partnership with Cynthia is aligned directly with MD Logic’s mission and philosophy. As a former bodybuilder and current fitness and wellness advocate, I have personally taken Creatine Monohydrate on and off for twenty years. During the research with Cynthia, it became clear that I need Creatine now more than ever as I enter my fifties. The research was robust and striking regarding the support for both muscle strength and cognitive support. I know that lean muscle mass is one of the most important indicators of health and life span; adding 3 grams of creatine per day in my daily diet is a no-brainer.”

We expect to launch this product by the third week of November 2022. We will be offering pre-launch incentive pricing starting next week. Please visit us at http://www.mdlogichealth.com for more information.

About Cynthia Thurlow

Cynthia Thurlow, NP, intermittent fasting and nutrition expert, author, and a two-time TEDx speaker. Cynthia is passionate about helping people find wellness through the healing power of nutrition and fasting. Cynthia hosts the Everyday Day Wellness Podcast and is Co-Host of the Intermittent Fasting Podcast. In addition, she has interviewed hundreds of top experts from around the world. Cynthia believes it is possible to feel better tomorrow than you do today and wants to equip you to experience that freedom!

“Wellness starts from within. I firmly believe that you can live a healthier life today through lifestyle choices and dietary changes than you did yesterday. The healing journey begins one step at a time.”

To learn more about Cynthia Thurlow, please, visit her at https://cynthiathurlow.com/my-story/

To listen to her Everyday Wellness Podcast, click on this link https://podcasts.apple.com/us/podcast/everyday-wellness/id1435214303

To listen to her Intermittent Fasting Podcast, click on this link https://podcasts.apple.com/us/podcast/the-intermittent-fasting-podcast/id1228755008

About MD Logic Health

MD Logic Health – Supplementing Life since 2005. At MD Logic Health, we promise to supplement your daily nutrition to help you live your best life. Our Company was created and founded by passionate health and wellness advocates. Our quality is at the core of who we are and what we offer. Our purity and efficacy come from the superior ingredients used in every MD Logic Health product. Individual dietary and non-dietary ingredients are tested for identity, strength, purity, and composition compliance to ensure maximum effectiveness before use. We believe our customers deserve the highest quality. To learn more about us, please visit us at https://www.mdlogichealth.com.

Follow MD Logic Health

https://www.facebook.com/mdlogichealth

https://www.instagram.com/mdlogichealth

https://www.twitter.com/mdlogichealth

https://www.tiktok.com/@mdlogichealth

https://www.linkedin.com/company/md-logic

MD LOGIC HEALTH CONTACT:

Jyoti Hardat

jhardat@mdlogichealth.com

Phone (877) 629-8711 x700

Share article on social media or email:



MOLLI Surgical’s Breast Cancer Technology Named in TIME’s 2022 Best Inventions


News Image

MOLLI Surgical’s wire-free and radiation-free breast cancer localization technology has been named to TIME’s 2022 Best Inventions list in the Medical Care category. Every year, TIME recognizes inventions that are solving compelling problems in creative ways.

When patients learn they have cancer, they face a difficult road ahead. If the patient needs surgery, MOLLI® is the smallest localization device on the market that marks the lesion for the surgeon to remove it precisely and confidently. Marking the lesion has traditionally been a difficult experience for the patient — MOLLI can help make this experience less traumatic.

MOLLI Surgical started after one patient stepped up and shared her journey using the traditional wire localization method — specifically, the anxiety, pain, and discomfort she experienced while waiting for surgery. Listening to her inspired both the device and the company. Since then, the team has been on a mission to drastically improve the overall experience for patients and care teams.

MOLLI is FDA-cleared and Health Canada-approved. It allows surgeons to pinpoint cancerous tissue faster and with confidence, offering an improved experience and better cosmetic outcomes for breast cancer patients. MOLLI can also be used to improve the lives of patients with other types of cancers. The wire-free technology includes the MOLLI Marker®, about the size of a sesame seed, which is reliably detected using the MOLLI Wand®. The MOLLI Tablet® then displays the distance down to the millimeter between the tip of the MOLLI Wand and the MOLLI Marker.

“Our team toils over every design choice to reduce the mental, physical and systemic burden on physicians and care teams while truly keeping the patient at the center of everything we do,” said Ananth Ravi, Ph.D., President and CEO of MOLLI Surgical Inc. “Words can’t convey how thrilled we are that TIME has recognized what we’ve achieved with MOLLI. This honor will continue to motivate us to improve the healthcare experience while making MOLLI available to as many people as possible.”

To learn more, please visit mollisurgical.com.

About MOLLI Surgical:

MOLLI Surgical started in the operating room, where surgeons were using dated tools to treat cancer patients — and we knew we could do better. Our surgical wand is precise, reliable, easy-to-use, and built with the realities of the operating room in mind. More importantly, it is built with patients in mind. Our technology replaces procedures to mark lesions with one that is more precise, efficient, and cost-effective. MOLLI Surgical is proud to build the advanced equipment that patients prefer to have and that physicians prefer to use. Follow us on Facebook, LinkedIn, Twitter, and YouTube.

Share article on social media or email:



Beyond Recurrence Detection in Post-Diagnosis Cancer Management, Upcoming Webinar Hosted by Xtalks


Personalis is committed to addressing some of the most pressing needs in the liquid biopsy space.

MRD is rapidly emerging as a key biomarker in therapy development and patient care, however, key challenges remain. Personalis is committed to addressing some of the most pressing needs in the liquid biopsy space.

In this webinar attendees will learn about the role of next-generation liquid biopsy assays in enabling: Earlier detection of disease recurrence; Utility in more disease indications, and at earlier stages of disease; Patient enrichment, screening/enrollment and surrogate endpoint analysis for clinical trials; Higher resolution variant tracking; And combining plasma and tissue analyses.

Register to learn how liquid biopsy assays go beyond recurrence detection in post-diagnosis cancer management.

Join Dan Norton, Associate Director, Product Management, Personalis Inc., for the live webinar on Friday, December 2, 2022, at 1pm EST (10am PST).

For more information, or to register for this event, visit Liquid Biopsy Assays: Beyond Recurrence Detection in Post-Diagnosis Cancer Management.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Modio Health’s Medical Staff Credentialing Technology Ranked by KLAS as a Top Credentialing Vendor for 4th Straight Year


The pandemic has shown the healthcare sector that it’s critical we get credentialing right, says John Bou, Co-Founder at Modio. When you factor in the ongoing staffing crisis and burnout, it’s clear that we need to get providers working when and where they are needed and as efficiently as possible.

Modio Health, a technology company transforming the management of healthcare providers and their credentials, was recognized by KLAS with an overall ranking 92.9 out of 100 — an increase from 92.7 [A] in 2019. Modio received a KLAS score of 93.8 for Overall Performance. Additionally, in the Credentialing 2022 report released in October, Modio received exceptional satisfaction ratings, including:

  • 97% Would You Buy Again
  • 96% Avoids Nickel-and-Diming
  • 96% Keeps All Promises
  • 93% Part of Long-Term Plans

Modio’s performance strengths also included sizable year-over-year increases in the following:

  • Communication and Partnership
  • Product Quality
  • Ease of Use
  • Meeting Customers’ Needs
  • Implementation Process
  • Phone/Web Support
  • Integration

Launched seven years ago, Modio has rapidly grown to be a leader in physician credentialing through development of an innovative and effective credentialing platform. More than 800 healthcare organizations nationwide manage over 400,000 providers using Modio to simplify and efficiently manage their credentialing processes. The cloud-based platform uses a blockchain type of mechanism that connects all entities associated with that provider with the same real-time data collection, which is automated, updated, easily accessible, and securely protected. Modio’s solution keeps organizations compliant and allows teams to securely manage and store credentials and licensure in one easily accessible location.

“The pandemic has shown the healthcare sector that it’s critical we get credentialing right,” says John Bou, COO and Co-Founder, Modio Health. “When you factor in the ongoing staffing crisis and burnout, it’s clear that we need to get physicians and nurses working when and where they are needed and as efficiently as possible. Our goal at Modio is to make this happen by providing healthcare organizations an innovative, modern credentialing process. This recognition from KLAS really shows us that we’re on the right track.”

The annual Best in KLAS report is based on impartial ratings and feedback from healthcare clients, helping health operations leaders make informed technology purchase decisions and driving vendor software and service improvements. Here are just a few samples of what Modio clients said:

“Our system before OneView didn’t perform well, so we were using spreadsheets. Going from that to a system that actually works has been a time-saver. We have seen our turnaround times decrease by about half because of the improved workflows. OneView has created efficiency for us and provided user accounts to our internal stakeholders. They have access to information in real time and use OneView as a self-service tool, so the amount of work we do for status updates has been reduced.” (page 11) — Modio customer, KlasResearch.com, October 2022

“I like the product. It is a great way to organize, track, and maintain our credentialing and paneling requirements. Prior to getting the Modio Health system, our system was all paper, and we were not doing well. Now, we are better and more efficient. We could definitely get more efficient once Modio Health connects our systems, but right now, the system is doing what it needs to. We are working with Modio Health to improve our efficiency and eliminate additional work. In terms of current capabilities, Modio Health has met deadlines on time. Sometimes we are waiting on our teams to do certain things, but Modio Health is pretty timely. They communicate very well and meet with us anytime to talk things out and problem-solve. Modio Health is a great company.” (page 12) — Modio customer, KlasResearch.com, October 2022

“One automation with the biggest impact on efficiency is the direct connection between the Modio Health system and our licensing board’s system. We can update clinical licenses right inside the system. That is nice. The system also connects with the OIG system, and that is very nice too.” (page 17) — Modio customer, KlasResearch.com, October 2022

Healthcare provider organizations can access the full credentialing report from KLAS at no cost online here or by going to klasresearch.com.

Share article on social media or email:

Knowable Garners “Contract Management Solution Provider of the Year” Award In 2022 LegalTech Breakthrough Awards Program


News Image

We do one thing extremely well: we give enterprises unprecedented visibility into their entire corpus of existing contracts so they can search, find, and answer questions fast – Mark Harris, CEO and co-founder of Knowable

LegalTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout legal technology companies, products and services around the globe, today announced that Knowable has been selected as “Contract Management Solution Provider of the Year” in the third annual LegalTech Breakthrough Awards program.

Knowable’s unique contract data conversion engine integrates machine learning with 350 human contract analysts providing QC across 25 languages. With a foundation of structured contract data, firms can achieve modern risk management and value capture. Knowable’s customers include many of the world’s leading companies, who benefit from the company’s 98% data accuracy guarantee.

“For decades, in-house legal professionals have struggled to solve a massive problem — a near total inability to access information from tens or hundreds of thousands of complex legal agreements they have with counterparties around the world. Answering simple questions is an odyssey. Larger contract initiatives, like regulatory activities, are even worse. It’s a mess that has plagued the industry for decades,” said Bryan Vaughn, Managing Director of LegalTech Breakthrough Awards. “In a world where data accuracy drastically affects outcomes, and where unreliable contract data has historically plagued legal operations and their business partners, Knowable is the one company in the market that delivers both accuracy and reliability. Congratulations on being our choice for the 2022 ‘Contract Management Solution Provider of the Year’ award.”

Enterprise clients interact with Knowable’s data through Knowable Insights, an award-winning platform purpose built for the management and interrogation of executed agreements. Knowable Insights delivers accurate data and analytics, organized by contract family hierarchies, surfacing in a few keystrokes answers that liberate revenue, manage cost, and reduce risk. Data long hidden in documents buried across SharePoint and repositories are brought to the surface and streamed into other enterprise systems as needed across legal, IT, finance, sales, and procurement.

While Knowable is primarily seen as a Contract System of Record for ongoing contract management, corporate transactors also use Knowable contract data in the M&A diligence process to uncover deal risks, accelerate velocity, and improve integration outcomes. Meanwhile, others leverage Knowable to enable their CLMs, so users can trust their contract data.

“We couldn’t be more proud to be recognized as the Contract Management Solution of the Year,” said Mark Harris, CEO and co-founder of Knowable. “We call Knowable ‘The Executed Agreements Company.’ We do one thing extremely well: we give enterprises unprecedented visibility into their entire corpus of existing contracts so they can search, find, and answer questions fast. It’s time for the long era of contract chaos in big companies to end, and that’s why we exist—to make everything, in every corporate contract, Knowable.”

The mission of the annual LegalTech Breakthrough Awards program is to conduct the industry’s most comprehensive analysis and evaluation of the top technology companies, solutions, and products in the legal technology industry today. This year’s program attracted more than 1,450 nominations from over 12 different countries throughout the world.

####

About LegalTech Breakthrough

Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the LegalTech Breakthrough Awards program is devoted to honoring excellence in legal technologies, services, companies and products. The LegalTech Breakthrough Awards program provides a forum for public recognition around the achievements of LegalTech companies and solutions in categories including Case Management, Client Relations, Data and Analytics, Documentation, Legal Education, Practice Management, eDiscovery and more. For more information visit LegalTechBreakthrough.com

About Knowable

Knowable is the world leader in post signature contract management, helping enterprises easily understand the opportunities and commitments in tens or hundreds of thousands of legal contracts. Knowable combines proprietary machine learning tools with scaled legal expertise to translate legal language into actionable structured data that provides unparalleled visibility and insights through its award-winning Knowable Insights platform and simple APIs. With Knowable, enterprises receive a trusted Contract System of Record that delivers 98% guaranteed accuracy across their entire corpus of contracts. After its spinoff from ALSP leader Axiom, Knowable entered a joint venture with LexisNexis® Legal & Professional. For more information, go to http://www.knowable.com.

Share article on social media or email:

Deep Bio and Visiopharm Announce a Collaborative Integration of a Clinical-Grade AI Prostate Cancer Solution with a Leading Digital Pathology Platform


Our dedication to AI for digital pathology has taken a major step forward with this collaboration and we are pleased to offer our latest technology to more labs and hospitals across the world through this opportunity.

Deep Bio, a leading AI biotech dedicated to cancer diagnosis, and Visiopharm, a world leader in AI-powered image analysis and tissue mining for research and diagnostics, announced a strategic partnership to provide pathologists access to the latest AI-powered prostate cancer solution.

AI-powered cancer diagnostics has been proving its utility not only in research, but increasingly in supporting and improving pathologists’ decisions, workflow efficiency, and diagnostic precision. Deep Bio’s deep learning-based CE-IVDD prostate cancer diagnosis support software, DeepDx® Prostate, empowers pathologists by identifying cancerous areas and grading their severity providing a Gleason scoring.

With this collaboration, DeepDx® strengthens Visiopharm’s diagnostic offering to its European diagnostic customers. This application expands pathologists’ accessibility to the latest cutting-edge H&E-based AI solutions for prostate cancer, which today is a large diagnostic indication that is both time and labor-intensive in diagnostic pathology labs. With its extensive AI-based image analysis solutions for multiple cancer types, Visiopharm’s platform is contributing to the global adoption of digital pathology and AI.

The first phase of integration of DeepDx® into Visiopharm’s digital pathology platform has been completed. In the next phases, Visiopharm will together with Deep Bio scale up the solution as interest grows. The two companies plan to add additional AI cancer pathology solutions over time for prostate and breast, among others.

“Digital transformation in healthcare is not a new concept anymore. Pathology, which has been slow to undergo digital transformation, is fast becoming digitalized due to a diverse range of AI solutions now available for implementation and validation”, said Sun Woo Kim, the CEO of Deep Bio. “Our dedication to AI for digital pathology has taken a major step forward with this collaboration and we are pleased to offer our latest technology to more labs and hospitals across the world through this opportunity. We will continue to support medical professionals to optimize their decisions which ultimately lead to the best patient care,” he added.

The second phase of integration will aim for tighter interoperability among the platform and AI solutions, helping both companies to better promote and distribute to healthcare institutions around the world.

Michael Grunkin, CEO of Visiopharm said, “We are seeing a lot of demand for this particular application among both our clinical research- and diagnostic customers and partners. In diagnostic workflows, this APP has the potential to support pathologists in automating time-consuming and repetitive work, while improving turn-around-time and standardization. This partnership with Deep Bio is a good example of how our scanner, LIMS, and PACS agnostic platform allow our users to benefit both from our own apps and best-in-class apps from our growing partner network, to gain access to a full diagnostic menu.”

About Deep Bio

Deep Bio Inc. is an AI healthcare company with in-house expertise in deep learning and cancer pathology. Our vision is to radically improve efficiency and accuracy of pathologic cancer diagnosis and prognosis, by equipping pathologists with deep learning-based IVD SaMDs (In Vitro Diagnostics Software as a Medical Device), for optimal cancer treatment decisions. Deep Bio is also actively engaged in the research space and maintains ongoing collaborations with top US medical centers. To learn more, visit http://www.deepbio.co.kr.

DeepDx® Prostate is a clinically-validated AI for prostate core needle biopsy tissue image analysis. Whole-slide images (WSIs) of H&E-stained biopsy tissue specimens are analyzed for prostate cancer, Gleason scores and grade groups. Extensively tested at 4 US CLIA labs (700k cores between 2019 and 2021), DeepDx® Prostate can alleviate the shortage of pathologists and the resultant increase in workload, while reducing diagnostic subjectivity and variability.

About Visiopharm

Visiopharm® is a world leader in AI-driven precision pathology software. Visiopharm’s pioneering image analysis tools support thousands of scientists, pathologists, and image analysis experts in academic institutions, biopharmaceutical industry, and diagnostic centers. AI-based image analysis and tissue mining tools support research and drug development research worldwide, while CE-IVD APPs support primary diagnostics. With highly advanced and sophisticated artificial intelligence and deep learning, Visiopharm delivers tissue data mining tools, precision results, and workflows. Visiopharm was founded in 2002 and is privately owned. The company operates internationally with over 780 user accounts and countless users in more than 40 countries. The company headquarters are in Denmark’s Medicon Valley, with offices in Sweden, England, Germany, Netherlands, and the United States.

Share article on social media or email:

Mass-Vac Introduces MV PosiTrap® Vacuum Inlet Traps that Help Prevent Premature Pump Failures


News Image

MV PosiTrap® Vacuum Inlet Traps come in 4” and 8” sizes for pumps up to 25 and 50 CFM, respectively and can be customized with a choice filter elements to meet specific OEM and end-user requirements.

MV PosiTrap® Vacuum Inlet Traps feature a fully positive seal at both ends to prevent contaminants from being ingested into the pump which can cause premature pump failure.

Mass-Vac, Inc. has introduced a line of vacuum pump inlet traps that are designed to be incorporated into systems and equipment used in small research laboratories and universities.

MV PosiTrap® Vacuum Inlet Traps feature a fully positive seal at both ends to prevent contaminants from being ingested into the pump which can cause premature pump failure and come in 4” and 8” sizes for pumps up to 25 and 50 CFM, respectively. Made of stainless steel with straight-through and right-angle ports and flange sizes from NW 25 up to ISO 80, they can be supplied with a wide variety of filter elements to match OEM requirements.

Designed to protect pumps from particulates, organic solvents, hydrogen peroxide, acids, and water vapor, filter media offered for MV PosiTrap® Vacuum Inlet Traps include stainless steel mesh, activated charcoal, molecular sieve, polypro in 20-0.1 micron pore size and Sodasorb®. Typical applications include ALD tools, freeze- and gel dryers, rotary evaporators, vacuum ovens, glove boxes, mass spectrometers, and vacuum sterilizers.

MV PosiTrap® Vacuum Inlet Traps are priced from $325.00 (list), depending upon configuration and the selected filter cartridges.

For more information contact:

Mass-Vac, Inc.

David Rolph, Marketing

247 Rangeway Rd. / P.O. Box 359

No. Billerica, MA 01862

(978) 667-2393 FAX (978) 671-0014

e-mail: drolph@massvac.com

http://www.massvac.com

Share article on social media or email:

Net Health Expands Partnership with Kno2 to Help Rehab Therapists Meet Demands for Care Coordination


News Image

Embedding Kno2’s cloud faxing and Direct Secure Messaging capabilities into Net Health Therapy for Clinics is a game changer for our clients, and we look forward to furthering our relationship with them.

Kno2®, the company leading the future of healthcare communication, and Net Health®, a top provider of specialty electronic health record (EHR) systems and advanced healthcare analytics, today announced the expansion of a partnership to provide an integrated solution for outpatient rehabilitation therapy clinics. Through this agreement, clients using the Net Health Therapy for Clinics EHR will be better able to seamlessly exchange patient information and improve care coordination and meet the demands for new care models, including value-based care.

In 2021, Net Health acquired Casamba, adding Net Health Therapy for Clinics (formerly Casamba Clinic) to their product portfolio. The product was a Kno2 Connected™ EHR for physical, speech, and occupational therapy providers. Post-acquisition, Net Health extended the licensing of the Kno2 Communication API to further enhance interoperability capabilities embedded in Net Health® Therapy for Clinics.

As the industry advances into new care models including those driven by value-based care, rehab therapy clinics are being asked to participate in data sharing and on-demand access to patient information at an accelerated pace. Data that needs to be communicated includes referrals, scheduling, care plan and incremental progress notes.

“At Net Health, we want to empower clinics to work smarter and grow faster,” says Net Health CEO Josh Pickus. “When we provide effective and efficient communication, we relieve the burden on clinics by not adding to their workload while improving their interaction with their referring providers. Embedding Kno2’s cloud faxing and Direct Secure Messaging capabilities into Net Health Therapy for Clinics is a game changer for our clients, and we look forward to furthering our relationship with them.”

One of these clients, Butte Premier Physical Therapy, a thriving outpatient physical therapy clinic in Chico, CA, is utilizing Kno2’s integration with Net Health to help improve their processes, efficiencies and outcomes. Through the company’s EHR, processes that used to take 11 steps are now handled with minimal mouse clicks that work seamlessly into existing workflows.

“The capabilities empowered by the Net Health and Kno2 integration save more than 10 hours of labor each week, eliminating more than 25% of the workload for full-time employees,” said Leigh Langerwerf, PT, DPT, owner and founder of Butte Premier Physical Therapy. “Our administrators save time, our health records are secure, and our workflow is modernized. We could not be more pleased that Net Health partnered with Kno2.”

The partnership between Net Health and Kno2 opens the door to further utilize the Kno2 Communication API with Net Health’s portfolio of EHR offerings in the future, providing even more opportunities for healthcare organizations across the country to streamline workflow and improve communications. Net Health’s specialty EHR software and analytics are in use at 23,000 healthcare facilities across the continuum of care. This includes facilities providing rehab therapy services in both acute and outpatient settings, as well as inpatient and outpatient wound care, employee health, occupational medicine and hospice facilities.

“We are pleased that Net Health recognizes the value of integration through Kno2,” said Jon Elwell, Kno2’s CEO. “Our goal is to bring rapid, cost-effective data sharing and interoperability solutions to as many providers as possible. This partnership with Net Health allows us to reach our goals for improving quality and outcomes while we create more efficiencies.”

About Net Health

Net Health provides specialized solutions for specialized care anywhere. Net Health solutions are trusted in more than 23,000 facilities across the continuum of care. Our EHR software enables caregivers and their organizations to engage effectively with patients, streamline documentation, staff efficiently, secure maximum appropriate reimbursement and maintain regulatory compliance. Our unique approach to analytics seamlessly presents insights in clinical and operational workflows to improve care and business performance. Net Health is a portfolio company of The Carlyle Group, Level Equity and Silversmith Capital Partners. http://www.nethealth.com.

About Kno2

The Kno2 network enables the secure, effortless and maximized exchange of patient information across patients, providers, payers and IT vendors. We are empowering healthcare to finally realize the true potential of interoperability by unleashing connectivity everywhere through a simple to use Communication API and robust tools for any business. With industry disrupting economics and our passion to include the underserved, Kno2 is democratizing healthcare communications and defining the new connected future of healthcare. With a single connection to Kno2, anyone can quickly gain access to a powerful network of connected networks, EHRs, HIEs, organizations, technologies and interoperability frameworks that gives the freedom to easily communicate with all. To learn more, visit http://www.kno2.com.

Share article on social media or email:

Supportiv Welcomes Deborah Francis and Ron Mosley, Accelerating Growth of Digital Peer-to-Peer Support and Conversational Care Through Enterprise Partnerships


Supportiv Growth and Partnerships Team

Supportiv Growth and Partnerships Team

Supportiv is demonstrating market traction and high user engagement. We’re really excited to have a world-class growth team joining us at this critical point in time when mental and emotional wellbeing is on everyone’s radar.

As Supportiv, a leader in digital peer-to-peer support and Natural Language Navigation™, continues to rapidly grow, the team welcomes health industry veterans Deborah Francis and Ron Mosley, FACHE to help scale access to its evidence-based on-demand Precision Peer Support™ and Conversational Care™ offerings–beyond the over 1.2 million individuals served to date.

Deborah Francis joins the Supportiv team as Senior Vice President of Growth. Ron Mosley, FACHE, joins Supportiv as Vice President of Strategic Partnerships. Both will accelerate Supportiv’s reach and ensure successful collaboration for health plan, employer, hospital system and employee assistance program (EAP) partnerships.

Deborah (Debbie) has over 20+ years of experience scaling digital technology and health and wellness platforms. She gained her behavioral health expertise across multiple successful health-tech ventures including leadership roles with Weight Watchers and Talkspace.

Ron, a former GE sales leader, health system consultant, and most recently with Transcarent, has a personal mission of working to improve access and value in healthcare. In line with Supportiv’s mission in mental health, to remove obstacles and fast-track feeling supported, he is focused on using his 15+ years of experience in employee benefits, health systems and working with providers and health plans, to drive improved client employee retention, engagement and care.

“The traditional mental health system can’t keep up with societal demand. Innovative, accessible, and scalable solutions like Supportiv are there to fill the gap. Expanding the team with such talented and experienced leaders like Debbie and Ron will expedite bringing peer support to the millions who need it across health plans, employers, hospital systems, universities and beyond,” says Helena Plater-Zyberk, Supportiv Co-Founder and CEO.

Adds Pouria Mojabi, Supportiv Co-Founder and President, “Supportiv’s unique approach of removing all barriers to care and eliminating the need for appointments is demonstrating market traction and high user engagement. We’re really excited to have a world-class growth team joining us at this critical point in time when mental and emotional wellbeing is on everyone’s radar.”

Q+A with Deborah Francis and Ron Mosley

Why Supportiv, why now?

National mental health needs are at an all-time high, with increasingly more Americans recognizing the problem.

Ron Mosley, FACHE calls attention to current supply-demand issues in the mental health space:

“Between provider shortages, untenable expenses for those who can access care, and the fact that there are people marginalized from mainstream mental healthcare, something has got to change. Supportiv addresses all of these pain points better than other offerings on the market. Moving beyond apps, Supportiv offers a greater magnitude of accessibility, at a fraction of the cost of other mental health tools. Users are met where they are, with connection and resources to improve their own outcomes.”

Deborah Francis reiterates:

“There’s now a national consensus about our nation’s mental health crisis. If we can’t currently meet escalating demand through clinical care, then we need novel, evidence-based solutions to fill the gap. The expansion of novel mental health tools, such as on-demand peer-to-peer support, benefits multiple stakeholder groups: consumers, employers, clinical care providers, and even government officials. Ron and I are both deeply excited to join Supportiv in providing an effective stopgap solution to so many in need.”

How did your past experiences lead you here?

Deborah Francis:

“My work has focused on scaling solutions to what I see as pressing, human problems. From weight management, to homecare, to digital behavioral health, I’ve seen that innovation alone is not enough. We need to communicate and spread the word about solutions that are innovative, readily available, and easy-to-use. That’s what drives me to grow access to Supportiv’s ‘bleeding edge’ technology.”

Ron Mosley:

“Throughout my career, I’ve walked the line between healthcare and technology. As these two fields continue to intersect, I see novel potential to address pain points for both consumers and corporations. For instance, tech can enable lower-cost, high-quality options that can positively impact all communities. This means healthier people and healthier workplaces and healthier bottom-lines.”

What excites you about Supportiv’s online, on-demand peer support?

Debbie Francis:

“The patented natural language understanding-based platform is available 24/7/365 – no appointment required. This provides immediate access (under a minute) to users when they need it most. Individuals receive live human support to cope with, problem solve and heal from their struggles. Supportiv puts the user first with the easiest user experience I’ve seen to date.”

Ron Mosley:

“With what’s happening in our country and around the world in mental health, there’s a need for solutions that expand access. Supportiv has a digital mental health solution that allows staff, associates, members, or employees to connect in a simple, high trust environment, where they can share and connect with real people that ‘get’ their lived experiences. And, in the end, they have another avenue where they may find care and healing.”

Supportiv is excited to bring these two seasoned professionals and their perspectives onto the team. The additions of Debbie Francis and Ron Mosley will help Supportiv in improving and growing service to existing and future clients, fulfilling its mission of increasing mental wellness nationwide.